News

Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...
Pharmaceuticals announced that data from the BEAT AML trial of revumenib in combination with venetoclax and azacitidine in ...
The FDA has granted approval to pembrolizumab for the treatment of adult patients with resectable, locally advanced HNSCC whose tumors express PD-L1 with a CPS of ≥1.
No effect on recurrence-free survival or overall survival was observed with the surgical interval duration among patients with cutaneous melanoma.
From RTÉ Radio 1's The History Show, writer Mary Russell tells the story of how the very first Ordnance Survey maps of ...
Anti-immigrant riots began in Ballymena, but economic grievances may not be enough to explain the phenomenon.
Revumenib was generally well-tolerated in combination with venetoclax/azacitidine in older, newly diagnosed mNPM1 and KMT2Ar AML patients – – Promising clinical activity and deep responses observed ...
Three major supermarkets, Asda, Morrisons and Sainsbury's, are accused of stocking imported beef despite pledges to source ...
A new exploit gives attackers a way to drop malware into your system's EFI partition and bypass Secure Boot entirely.
Our mission is to impact the sustainability of Oklahoma’s water resources and the aquatic and public health of Oklahoma by providing leadership in finding solutions for the important water-related ...
A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...